טימנטין 3.2 ג'

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

CLAVULANIC ACID AS POTASSIUM 200 MG/VIAL; TICARCILLIN AS DISODIUM 3 G/VIAL

Disponible depuis:

GLAXO SMITH KLINE (ISRAEL) LTD

Code ATC:

J01CR50

forme pharmaceutique:

POWDER FOR SOLUTION FOR INFUSION

Mode d'administration:

I.V

Fabriqué par:

BIOPHARMA S.R.L, ITALY

Groupe thérapeutique:

COMBINATIONS OF PENICILLINS

indications thérapeutiques:

Timentin is an injectable antibiotic agent with a broad spectrum of bactericidal activity against a wide range of Gram-positive and Gram-negative, aerobic and anaerobic bacteria. The presence of clavulanate in the formulation extends the spectrum of activity of ticarcillin to include many beta-lactamase producing bacteria normally resistant to ticarcillin and other beta-lactam antibiotics. Timentin is indicated for the treatment of infections in which susceptible organisms have been detected or are suspected. Typical indications include: severe infections in hospitalised patients and proven or suspected infections in patients with impaired or suppressed host defences including: septicaemia, bacteraemia, peritonitis, intra-abdominal sepsis, post-surgical infections, bone and joint infections, skin and soft tissue infections, respiratory tract infections, serious or complicated renal infections (e.g. pyelonephritis), ear, nose and throat infections.

Date de l'autorisation:

2012-08-01